Patents Assigned to Latitude Pharmaceuticals Inc.
  • Patent number: 10888616
    Abstract: This invention relates to ready-to-use and safe solution compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon, an acid, anti-gelling polyol, a stabilizing-salt, viscosity reducer and an antioxidant, have a final pH between about 2 and 5, and is gel-free, chemically-stable, and pump-able.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: January 12, 2021
    Assignee: LATITUDE PHARMACEUTICALS, INC.
    Inventors: Hailiang Chen, Andrew Xian Chen, Norman Keith Orida
  • Patent number: 10376560
    Abstract: This invention relates to aqueous solution compositions of vancomycin that are stable, ready for use and do not require reconstitution.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: August 13, 2019
    Assignee: LATITUDE PHARMACEUTICALS, INC.
    Inventor: Andrew Xian Chen
  • Patent number: 10369101
    Abstract: The present application provides parenteral compositions of diclofenac or its pharmaceutically acceptable salt and methods for making and using such compositions. Some of the compositions of the present application has one or more following properties: (1) ready to be injectable, (2) in the form of an oil-in-water emulsion, (3) stable under appropriate storage conditions, (4) containing therapeutically effective amount of diclofenac or its pharmaceutically acceptable salt, (5) sterilizable by filtration (6) containing components acceptable by regulatory agencies (e.g. the FDA), (7) containing low oil content and thus not exacerbating hyerlipidemia, and (8) is neither hyperallergenic nor vein irritating.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: August 6, 2019
    Assignee: LATITUDE PHARMACEUTICALS INC.
    Inventors: Franklin Okumu, Andrew X. Chen, Hailiang Chen
  • Patent number: 10238717
    Abstract: This invention relates to compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon and a sugar, have a final pH between about 1.5 and 3, and are gel-free, chemically-stable at body temperature and pump-able.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: March 26, 2019
    Assignee: LATITUDE PHARMACEUTICALS, INC.
    Inventor: Andrew Chen
  • Publication number: 20180236079
    Abstract: This invention relates to ready-to-use and safe solution compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon, an acid, anti-gelling polyol, a stabilizing-salt, viscosity reducer and an antioxidant, have a final pH between about 2 and 5, and is gel-free, chemically-stable, and pump-able.
    Type: Application
    Filed: February 22, 2018
    Publication date: August 23, 2018
    Applicant: Latitude Pharmaceuticals, Inc.
    Inventors: Hailiang CHEN, Andrew Xian CHEN, Norman Keith ORIDA
  • Publication number: 20170304396
    Abstract: This invention relates to aqueous solution compositions of vancomycin that are stable, ready for use and do not require reconstitution.
    Type: Application
    Filed: July 13, 2017
    Publication date: October 26, 2017
    Applicant: LATITUDE PHARMACEUTICALS, INC.
    Inventor: ANDREW XIAN CHEN
  • Publication number: 20170202926
    Abstract: This invention relates to compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon and a sugar, have a final pH between about 1.5 and 3, and are gel-free, chemically-stable at body temperature and pump-able.
    Type: Application
    Filed: March 30, 2017
    Publication date: July 20, 2017
    Applicant: Latitude Pharmaceuticals, Inc.
    Inventor: Andrew Chen
  • Publication number: 20170189532
    Abstract: The present invention is directed to compositions and methods of preparation of phospholipid depots that are injectable through a fine needle.
    Type: Application
    Filed: October 28, 2016
    Publication date: July 6, 2017
    Applicant: Latitude Pharmaceuticals Inc.
    Inventors: Andrew Xian Chen, Hailiang Chen
  • Patent number: 9517202
    Abstract: The present invention is directed to phospholipid compositions and methods of preparation of phospholipid depots that are injectable through a fine needle. The phospholipid depots prepared by the methods described herein comprise nanometer-sized phospholipid particles and exhibit a higher degree of structural order compared to compositions prepared by other methods.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: December 13, 2016
    Assignee: LATITUDE PHARMACEUTICALS INC.
    Inventors: Andrew Xian Chen, Hailiang Chen
  • Patent number: 9370486
    Abstract: In certain embodiments, this invention sets forth compositions, methods, and uses regarding a nanoemulsion composition that comprises a fat-soluble vitamin K and can therapeutically replace Phytonadione Injectable Emulsion, USP.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: June 21, 2016
    Assignee: LATITUDE PHARMACEUTICALS INC.
    Inventor: Andrew Xian Chen
  • Publication number: 20130189316
    Abstract: In certain embodiments, this invention sets forth compositions, methods, and uses regarding a nanoemulsion composition that comprises a fat-soluble vitamin K and can therapeutically replace Phytonadione Injectable Emulsion, USP.
    Type: Application
    Filed: November 28, 2012
    Publication date: July 25, 2013
    Applicant: Latitude Pharmaceuticals Inc.
    Inventor: Latitude Pharmaceuticals Inc.
  • Publication number: 20120316108
    Abstract: The present invention is directed to compositions and methods of preparation of phospholipid depots that are injectable through a fine needle.
    Type: Application
    Filed: June 14, 2012
    Publication date: December 13, 2012
    Applicant: Latitude Pharmaceuticals Inc.
    Inventors: Andrew Xian Chen, Hailiang Chen